Born in Seoul, South Korea, Bill Kim is an award-winning Chicago chef and restauranteur known for merging his Korean heritage with the food of his Midwestern upbringing. He was one of the first ...

The label for diabetes treatment Ozempic, popularized by its use as a weight loss drug, will now list blocked intestines as a potential side effect. Two other similar drugs, Wegovy and Mounjaro, ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy from the FDA. If drugmakers want healthier people to have access to the ...

HEALTH. ED TO YOU. LET’S PICK IT UP RIGHT THERE. MARIA. HERE TO DISCUSS SOME MORE. IS DOCTOR TODD AND FAMILIAR FACE HERE AT 430 ON NEWSCENTER 5. CHIEF OF INFECTIOUS DISEASES AT SOUTH SHORE HEALTH.

In March 2025, the U.S. Food and Drug Administration expanded approval so it can be used earlier in treatment. Previously, the FDA had approved 177 Lu-PSMA-617 only for patients with metastatic ...

This latest drug is among *** new group showing promise. The FDA granted accelerated approval for another experimental Alzheimer's drug called Lean IAB in January, Robert Eggy with the Alzheimer's ...

MAKARY TALKS — FDA Commissioner Marty Makary announced Thursday that the agency will soon provide clear guidelines to vaccine manufacturers for annually updating their Covid-19 shots.

US FDA Clears First Blood Test for Alzheimer's Detection By Christy Santhosh (Reuters) -The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's ...

The test, called the Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, is for adults 55 and older who are showing signs and symptoms of Alzheimer’s disease, the FDA announced Friday. It works by ...

Delta Air Lines Inc. will stop selling tickets under the “basic economy” label that many large carriers have adopted in recent years to compete with no-frills offerings of discount competitors.

The FDA said in a news release it will conduct a scientific review of the children's products by Oct. 31 with the aim of removing them from the market. It is not immediately clear whether the ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to place artificial intelligence programs at the center of its medical ...